1,516 articles
Harriette G.C. Van Spall
Harriette G.C. Van Spall is a Canadian cardiologist and clinical trialist at McMaster University whose research focuses on heart failure care, digital health equity, and inclusive trial design.
Harry Goldblatt
Harry Goldblatt (1891–1977) was an American pathologist whose 1934 experiment producing persistent high blood pressure in dogs by clamping the renal arteries created the first animal model of hypertension.
Harry Hemingway
Harry Hemingway is a British physician-scientist, Professor of Clinical Epidemiology at University College London, whose research on electronic health records has shaped cardiovascular prevention guidelines and policy.
Harry J.G.M. Crijns
Harry J.G.M. Crijns is a Dutch cardiologist and emeritus professor at Maastricht University known for the RACE trials, which showed lenient rate control is safe in atrial fibrillation.
Harry Klinefelter
Harry Klinefelter, also known as Harry Fitch Klinefelter, Jr., is an American endocrinologist at Johns Hopkins whose name is attached to Klinefelter syndrome from a 1942 paper.
Harvey D. White
Harvey D. White is a New Zealand interventional cardiologist at Auckland City Hospital whose 1987 trial showed thrombolytic therapy improves survival after heart attack, earning the 1998 Prince Mahidol Award.
Harvey Feigenbaum
Harvey Feigenbaum is an American cardiologist at the Indiana University School of Medicine, called the "Father of Echocardiography" for pioneering the use of ultrasound to examine the heart.
Hei Sook Sul
Hei Sook Sul is a metabolic physiologist, professor and chair of Nutritional Sciences and Toxicology at UC Berkeley, known for discovering Pref-1 and AdPLA's roles in fat-cell biology.
Heikki V. Huikuri
Heikki V. Huikuri, born 1952, is a Finnish cardiologist and emeritus professor at the University of Oulu known for research on heart-rate variability and sudden cardiac death.
Heiko Lickert
Heiko Lickert is a German developmental and stem cell biologist who studies pancreatic beta cells and directs the Institute of Diabetes and Regeneration Research at Helmholtz Munich since 2011.
Heimo Ehmke
Heimo Ehmke is a German physician and physiologist at the University Medical Center Hamburg-Eppendorf, where he directs the Institute of Cellular and Integrative Physiology and studies hypertension and cardiac arrhythmias.
Hein J.J. Wellens
Hein J.J. Wellens (Hein J. Wellens) was a Dutch cardiologist, born 1935 and died 2020, who was a founder of clinical cardiac electrophysiology and built Maastricht's arrhythmia service into an internationally recognized center.
Heinrich Taegtmeyer
Heinrich Taegtmeyer (H. Taegtmeyer) is a cardiologist known for showing that metabolic changes drive remodeling of the failing and diabetic heart; he has taught at UTHealth Houston since 1982.
Helen H. Hobbs
Helen H. Hobbs is an American physician-scientist at UT Southwestern whose discovery that PCSK9 mutations lower LDL cholesterol led to a new class of cholesterol drugs.
Helen M. Colhoun
Helen M. Colhoun, also published as Helen Colhoun, is a clinical epidemiologist at the University of Edinburgh known for leading the CARDS and SELECT diabetes trials.
Helena Edlund
Helena Edlund is a Swedish molecular developmental biologist and diabetes researcher, professor at Umeå University, known for showing that Pdx1 is required for pancreas development.
Helmut Drexler
Helmut Drexler (1951–2009) was a German cardiologist who led the Department of Cardiology and Angiology at Hannover Medical School and led the BOOST bone-marrow cell therapy trial.
Henning Bundgaard
Henning Bundgaard is a Danish cardiologist, clinical professor at the University of Copenhagen and senior consultant at Rigshospitalet, known for leading the POET and POTCAST trials.
Henri Huchard
Henri Huchard (1844–1910) was a French physician at the Hôpitaux Bichat and Necker, a foremost Paris teacher remembered for "maladie de Huchard", continued hypertension causing arteriosclerosis.
Henry Friesen
Henry George Friesen (1934–2025) was a Canadian endocrinologist from Morden, Manitoba, who first isolated human prolactin and, as MRC president, laid the foundation for the CIHR.
Henry Krum
Henry Krum (1958–2015) was an Australian clinical pharmacologist at Monash University and The Alfred Hospital in Melbourne, known for establishing β-blockers as standard therapy in heart failure.
Henry M. Kronenberg
Henry M. Kronenberg is an American physician-scientist who leads the Endocrine Unit at Massachusetts General Hospital and is known for cloning parathyroid hormone DNA and its receptor.
Henry N. Ginsberg
Henry N. Ginsberg is an American physician-scientist at Columbia University known for research on apoB lipoproteins, insulin resistance, and atherosclerosis, and for leading the ACCORD Lipid trial.
Herbert A. Selenkow
Herbert A. Selenkow (1923–2007) was an American endocrinologist and Harvard associate professor who directed the Thyroid Laboratory at Peter Bent Brigham Hospital in Boston for twenty years.
Herbert Benson
Herbert Benson (1935–2022) was an American cardiologist at Harvard Medical School who defined the relaxation response, the counterpart of fight-or-flight, and wrote the 1975 bestseller The Relaxation Response.
Heribert Schunkert
Heribert Schunkert is a German cardiologist who has been Professor of Cardiology at the Technical University of Munich and Director of Cardiology at the German Heart Centre Munich since 2012.
Herman A. Taylor Jr.
Herman A. Taylor Jr. is an American cardiologist who founded and led the Jackson Heart Study and directs the Cardiovascular Research Institute at Morehouse School of Medicine.
Herman Baker
Herman Baker, born 1926, is an American clinical biochemistry and nutrition researcher known for his work on biotin deficiency at the East Orange VA Medical Center.
Hertzel Gerstein
Hertzel Gerstein is a Canadian endocrinologist at McMaster University who led large diabetes trials, including REWIND, and was elected a Royal Society of Canada Fellow in 2023.
Hiroaki Shimokawa
Hiroaki Shimokawa (下川 宏明) is a Japanese cardiologist who created the first animal model of coronary artery spasm and identified Rho-kinase as its molecular switch.